Home Therapies Lung Diseases

Lung Diseases

in Malaysia

What are Lung Diseases?

Lung diseases occur in two stages. In the first stage, a virus or toxin causes inflammation in the liver, which causes the immune system to initiate a protection response (M1) or a repair response (M2). The second stage occurs when the immune system mistakenly initiates the wrong response, causing programmed and unprogrammed cell death, elimination, and inflammation.

 

wjMSCs Treat Lung Diseases by

01Modulating inflammation and immune responses,
02Restoring and preserving the architecture of the lungs,
03Differentiating into functional lung cells,
04Repairing and preventing fibroids,
05Decreasing collagen deposition, and
06Reducing or preventing pulmonary oedema.

Interested?

Talk to Your Primary Doctor First

They're pros who can give you personalized advice and recommend the latest treatment options that suit your unique condition.

One Size Does Not Fit All

Our doctors decide how many wjMSCs, the transfusion method, and the rounds of treatment that you need based on your medical records. So, be sure to send them to your patient liaison.

Research Findings

Multiple universities and institutions from across the globe have examined the efficacy of using wjMSCs to treat lung diseases and reported promising outcomes.

Democritus University of Thrace, Greece
Prevented the deterioration of functional lung parameters (forced ventilation capacity and carbon monoxide diffusion capacity) in idiopathic pulmonary fibrosis patients.
University of Miami, United States
Slowed the decline of forced ventilation capacity and carbon monoxide diffusion capacity of idiopathic pulmonary fibrosis patients.
Federal Research and Clinical Center of Federal Medical-Biologic Agency, Russia
Improved the six‐minute walk distance and forced ventilation capacity of idiopathic pulmonary fibrosis patients, and slowed the decline of carbon monoxide diffusing capacity.
Shaoxing Second Hospital, China
Decreased the serum surfactant protein D, interleukin-6, and interleukin-8 levels of acute respiratory distress syndrome patients.
Chang Gung University College of Medicine, Taiwan
Decreased circulating inflammatory biomarkers and increased the immune cell markers of acute respiratory distress syndrome patients.
Centre Hospitalier de Valence, France
Achieved asymptomatic and full remission in sarcoidosis complicated by acute myeloid leukaemia.
Federal University of Rio de Janeiro, Brazil
Increased perfusion at the base of both lungs in silicosis patients.
Guangzhou Medical University, China
Ameliorated cough and chest distress, improved pulmonary function, decreased serum immunoglobulin G levels, and achieved partial absorption of nodular and reticulonodular lesions in silicosis patients.
University of Vermont, United States
Significantly decreased circulating C-reactive protein levels in chronic obstructive pulmonary disease patients.
Universidade de São Paulo, Brazil
Improved the spirometry results and quality of life of chronic obstructive pulmonary disease patients, and slowed the pathological degeneration.
Leiden University Medical Center, the Netherlands
Increased expression of CD31 by 3-fold in pulmonary emphysema patients, suggesting responsiveness of microvascular endothelial cells in the most severely affected parts of the lungs.
Universidade Estadual Paulista, Brazil
Significantly improved the quality of life, changed the course and slowed the progression of the disease in emphysema patients.

What Makes Us Different?

Premium grade passage 2 wjMSCs

Our premium grade passage 2 wjMSCs are ethically derived from the umbilical cord tissues of healthy human babies that have been delivered after 37 weeks of gestation.

cGMP & ISO 9001 certified

Our laboratory is not only current goods & manufacturing practices (cGMP) certified, but ISO 9001 certified as well, both of which are internationally recognised standards for quality management systems (QMS).

Crafters of high-quality products

Our bio-safety level (BSL) 2 laboratory adheres to international standard operating procedures to ensure cleanliness and sterility as well as the safety of the environment.

Patient journey for international patients

Enquire now

The Patient Liaison that you are assigned will require your medical information. To streamline the process, either send your existing medical records to your Patient Liaison or get a medical test done in your country of residence and send it to your Patient Liaison.

Planning your treatment

Your Patient Liaison will send your medical reports to our doctors, who will tailor a personalised treatment plan for you or request that you get more medical tests done in your country of residence and send it to your Patient Liaison.

Ready to begin?

Once you've agreed to the treatment plan, let your Patient Liaison know when you'd like to start your treatment. They'll coordinate with our doctors and book a treatment slot for you.

Secure your spot

Let your Patient Liaison know how many people will be accompanying you to Malaysia and if you have any special requirements, such as ambulance or wheelchair assistance. You'll need to pay a deposit depending on the duration of your treatment, number of travellers, and special needs so that your Patient Liaison may make appropriate hotel bookings and transport arrangements.

Visas made easy

Visit the Immigration Department of Malaysia's website to check if you need a visa to enter the country. You may apply for an electronic visa (eVisa) here. Let your Patient Liaison know if you require an Invitation Letter and they'll send you one.

Book your flight tickets

When booking your flight tickets, it's recommended to arrive two days before your treatment date and to depart the day after your treatment ends.

Malaysia Digital Arrival Card (MDAC) registration

Two days before your arrival in Malaysia, go to this link to register yourself and all other travellers.

Arrival & airport transfer

Your Patient Liaison will organise your airport transfer to the hotel and send you your driver's contact details via email. Log in to "Airport WiFi" to check your email once you've landed at KLIA and contact your driver.

Check-in & pay for treatment

Your Patient Liaison will meet you at the hotel and help you check-in. You will be required to pay the remainder of your treatment fee in order for the laboratory to begin preparing the products for your treatment, which will be two days later. We accept cash, online funds transfers, PayPal, and credit / debit cards (Visa, MasterCard, American Express, JCB, Union Pay).

Let the healing begin

Your Patient Liaison will arrange transportation to and from the treatment facility on the treatment date and walk you through the registration and discharge processes.

Show more

Hear from Our Patients

More than 200 people have chosen Cyrona, why not you?
Learn more about our

Lung Diseases

Therapy Programme
Captcha

Download our complimentary eBook!